다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Hepion Pharmaceuticals Inc (HEPA)
Hepion Pharmaceuticals Inc (HEPA) 뉴스

HEPA

Hepion Pharmaceuticals (HEPA)

Hepion Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HEPA

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/22	22:00	GlobeNewswire Inc.	Hepion Pharmaceuticals Announces $9.0 Million Public Offering	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2025/01/13	21:00	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/12/11	22:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/12/11	22:00	GlobeNewswire Inc.	Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/12/05	22:48	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/12/02	22:53	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/12/02	22:00	GlobeNewswire Inc.	Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/11/22	07:01	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/11/22	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/11/11	22:00	GlobeNewswire Inc.	Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/09/04	22:25	GlobeNewswire Inc.	Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/08/07	22:08	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/08/07	22:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/07/22	21:00	GlobeNewswire Inc.	Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/05/22	06:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/05/16	05:46	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/04/20	05:30	GlobeNewswire Inc.	Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/02/16	23:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/02/16	22:00	GlobeNewswire Inc.	Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/02/15	05:38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/01/04	07:15	GlobeNewswire Inc.	Hepion Pharmaceuticals to Present at NASH-TAG 2024	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2024/01/04	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/12/07	22:00	GlobeNewswire Inc.	Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/11/29	06:15	GlobeNewswire Inc.	Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/11/14	06:05	GlobeNewswire Inc.	Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/11/10	22:50	GlobeNewswire Inc.	Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/11/09	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/10/25	21:30	GlobeNewswire Inc.	Hepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/09/29	21:00	GlobeNewswire Inc.	Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules	NASDAQ:HEPA	Hepion Pharmaceuticals Inc
2023/09/22	05:05	GlobeNewswire Inc.	Hepion Pharmaceuticals to Participate in 2023 Cantor Global Healthcare Conference	NASDAQ:HEPA	Hepion Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:HEPA

1 2 3 4 5 6 7 8 9 다음 >>

American Express

Deutsche Telekom (QX)

Verizon Communications

US Dollar vs Euro

Financial Select Sector

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관